Literature DB >> 31632789

Increasing T stage is associated with the need for more extensive lymph node assessment in clinical stage I non-small cell lung cancer.

Andrew Brownlee1, Seth B Krantz1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31632789      PMCID： PMC6783750          DOI： 10.21037/jtd.2019.08.119

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

1.  Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?

Authors:  Matthew J Bott; Aalok P Patel; Traves D Crabtree; Graham A Colditz; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Stephen Broderick; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2015-08-13       Impact factor: 4.330

2.  Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Authors:  Gary M Strauss; James E Herndon; Michael A Maddaus; David W Johnstone; Elizabeth A Johnson; David H Harpole; Heidi H Gillenwater; Dorothy M Watson; David J Sugarbaker; Richard L Schilsky; Everett E Vokes; Mark R Green
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

3.  Stage migration: results of lymph node dissection in the era of modern imaging and invasive staging for lung cancer.

Authors:  Bilal H Kirmani; Robert C Rintoul; Thida Win; Cormac Magee; Lavinia Magee; Cliff Choong; Francis C Wells; Aman S Coonar
Journal:  Eur J Cardiothorac Surg       Date:  2012-04-23       Impact factor: 4.191

4.  Optimal Lymph Node Examination and Adjuvant Chemotherapy for Stage I Lung Cancer.

Authors:  Jie Dai; Ming Liu; Yang Yang; Qiuyuan Li; Nan Song; Gaetano Rocco; Alan D L Sihoe; Diego Gonzalez-Rivas; Hon Chi Suen; Wenxin He; Liang Duan; Jiang Fan; Deping Zhao; Haifeng Wang; Yuming Zhu; Chang Chen; Robert B Diasio; Gening Jiang; Ping Yang; Peng Zhang
Journal:  J Thorac Oncol       Date:  2019-04-19       Impact factor: 15.609

5.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

6.  Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer.

Authors:  Raymond U Osarogiagbon; Obiageli Ogbata; Xinhua Yu
Journal:  Ann Thorac Surg       Date:  2013-11-20       Impact factor: 4.330

7.  Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer Database.

Authors:  Seth B Krantz; Waseem Lutfi; Kristine Kuchta; Chi-Hsiung Wang; Ki Wan Kim; John A Howington
Journal:  Ann Thorac Surg       Date:  2017-11-06       Impact factor: 4.330

8.  Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer ≤2 cm.

Authors:  Jinlin Cao; Jinming Xu; Zhehao He; Ping Yuan; Sha Huang; Wang Lv; Jian Hu
Journal:  J Thorac Cardiovasc Surg       Date:  2018-04-06       Impact factor: 5.209

9.  Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.

Authors:  Wenhua Liang; Jiaxi He; Yaxing Shen; Jianfei Shen; Qihua He; Jianrong Zhang; Gening Jiang; Qun Wang; Lunxu Liu; Shugeng Gao; Deruo Liu; Zheng Wang; Zhihua Zhu; Calvin S H Ng; Chia-Chuan Liu; René Horsleben Petersen; Gaetano Rocco; Thomas D'Amico; Alessandro Brunelli; Haiquan Chen; Xiuyi Zhi; Bo Liu; Yixin Yang; Wensen Chen; Qian Zhou; Jianxing He
Journal:  J Clin Oncol       Date:  2016-12-28       Impact factor: 44.544
  9 in total
  1 in total

1.  Development and validation of a nomogram prognostic model for patients with neuroendocrine tumors of the thymus.

Authors:  Jia-Yu Tang; Hui-Jiang Gao; Guo-Dong Shi; Xiao-Kang Guo; Wen-Quan Yu; Hua-Feng Wang; Yu-Cheng Wei
Journal:  Thorac Cancer       Date:  2020-07-12       Impact factor: 3.500
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.